Latest News

Liv Labs Inc., a consumer healthtech company making solutions for urinary incontinence, announces that on February 13, 2023 the first study participant enrolled in the Pippa Pessary Study, a pivotal clinical trial to evaluate the...

Liv Labs Inc. joins the inaugural cohort of 51 Labs, sponsored by MATTER, the premier healthcare incubator and innovation hub, alongside Astellas Pharma US, Walgreens, BayCare, Parkview Health, University of Chicago Medicine and Capita3​​.

Liv Labs Inc., a venture-backed consumer healthtech company, welcomes Melissa Stendahl, PT, DPT to leadership team.

Liv Labs has been awarded a National Science Foundation (NSF) Small Business Innovation Research (SBIR) grant for $256,000 to conduct research and development (R&D) work on. . .

Liv Labs Inc., a venture-backed consumer healthtech company, announces the appointment of Tim McKeown to the position of Vice President, Product and Commercialization. McKeown has decades of experience leading...

Liv Labs Inc. announces venture backing from Silicon Valley VC, Y Combinator. YC is reputed to have a talent for spotting high-potential, high-growth startups early...

Liv Labs gratefully announces an investment of non-dilutive governmental funding from the Eunice Kennedy Shriver National Institute of Child Health & Human Development. These funds are part of...